Trialbee Partners With Savvy Cooperative
Trialbee has announced a strategic partnership with Savvy Cooperative. This partnership primarily addresses two pain points for patients—the challenge of finding appropriate clinical trials and the lack of opportunity to express their experiences to the industry as consumers of healthcare—an area still ripe for disruption.
As a practical example, Savvy Cooperative members will be introduced to specific clinical trials with an invitation to participate in pre-screening and referral to sites via the Trialbee Honey platform. At the end of the process, all potential participants who come through Honey, regardless of channel, will be invited to join the #AskPatients™ community to share their experiences for future research. While the collaboration is inclusive of all members in the Savvy community, lupus and multiple sclerosis have been selected as pilot indications to demonstrate the power of the partnership as these patients are simultaneously active yet traditionally under recruited.
Reference
Trialbee Partners with Savvy Cooperative to Bring the Voice of the Patient into Clinical Trials Earlier. (2023, March 29). Cision PRWeb.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
FDA Expands Farapulse PFA Approval to Persistent AF After Strong ADVANTAGE AF Trial Results
July 7th 2025Boston Scientific’s Farapulse Pulsed Field Ablation System is now approved for treating persistent atrial fibrillation, following 12-month data from the ADVANTAGE AF trial showing strong safety, high freedom from AF, and no major complications.
